Skip to main content
Fig. 2 | BMC Pregnancy and Childbirth

Fig. 2

From: Recombinant human thrombopoietin therapy for primary immune thrombocytopenia in pregnancy: a retrospective comparative cohort study

Fig. 2

Screening for the factors associated with treatment response (in the first week). Forest plot based on univariate analysis for maternal baseline characteristics and baseline blood values as potential risk factors. BMI: body mass index; MPV: mean platelet volume; PDW: platelet distribution width; P-LCR: platelet-large cell ratio; PLR: platelet-lymphocyte ratio

Back to article page

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us